Moonlake Immunotherapeutics (MLTX) PT Lowered to $25 at Oppenheimer
Tweet Send to a Friend
(Updated - October 7, 2025 9:04 AM EDT)
Oppenheimer analyst Andreas Argyrides lowered the price target on Moonlake Immunotherapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Andreas Argyrides lowered the price target on Moonlake Immunotherapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
